Technology
Health
Medical
Daxor
$14.269876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.61 (4.47%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Daxor and other stocks, options, ETFs, and crypto commission-free!
About
Daxor Corporation, also called Daxor, is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. Read More The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.
Employees
—
Headquarters
New York, New York
Founded
1970
Market Cap
51.14M
Price-Earnings Ratio
—
Dividend Yield
0.37
Average Volume
91.09K
High Today
$14.48
Low Today
$13.85
Open Price
$13.93
Volume
7.25K
52 Week High
$19.95
52 Week Low
$4.30
Collections
Technology
Health
Medical
Biotechnology
US
North America
News
Seeking AlphaFeb 22
Daxor's BVA-100 demonstrates ease of use in critically ill patients
Daxor (DXR) is up 2% in response to new research supporting the value proposition of its BVA-100 test. The results were presented at Society of Critical Care Medicine Congress in San Diego. Recent studies showed 97% agreement between one (BVA-100) and five blood draws in critically ill patients and that BVA-100 was the most accurate way to establish blood volume. Reducing blood sampling will result in more rapid reporting of test results with a corresponding reduction in the quantity of blood sampled, tec...
Price Paid on Robinhood
9% Higher
Right Now
52 Week Low
$4.30
Average Price Paid
$13.06
52 Week High
$19.95
Earnings
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
—
Actual
—